EIDD-1931

• Description :

  EIDD-1931 (Beta-d-N4-hydroxycytidine; NHC) is a novel nucleoside analog and behaves as a potent anti-virus agent. EIDD-1931 effectively inhibits the replication activity of venezuelan equine encephalitis virus (VEEV), Chikungunya virus (CHIKV) and hepatitis C virus (HCV) [1].

• Product Name Alternative :

  β-D-N4-hydroxycytidine; NHC

• UNSPSC :

  12352005

• Hazard Statement :

  H228, H315, H319

• Target :

  CHIKV; Enterovirus; HCV; SARS-CoV; Topoisomerase

• Type :

  Reference compound

• Related Pathways :

  Anti-infection; Cell Cycle/DNA Damage

• Applications :

  Neuroscience-Neuromodulation

• Field of Research :

  Infection

• Assay Protocol :

  https://www.medchemexpress.com/beta-d-n4-hydroxycytidine.html

• Purity :

  99.98

• Solubility :

  DMSO : 100 mg/mL (ultrasonic) |H2O : ≥ 25 mg/mL

• Smiles :

  O=C(N/1)N([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)C=CC1=N/O

• Molecular Formula :

  C9H13N3O6

• Molecular Weight :

  259.22

• Precautions :

  H228, H315, H319

• References & Citations :

  4

• Shipping Conditions :

  Room Temperature

• Storage Conditions :

  -20°C, 3 years; 4°C, 2 years (Powder)

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported

• CAS Number :

  [3258-02-4]